Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease.
Adolescent
Adult
Age of Onset
Bone and Bones
/ diagnostic imaging
DNA Mutational Analysis
Frameshift Mutation
Gene Silencing
Heterozygote
Humans
Middle Aged
Monocytes
Osteitis Deformans
/ diagnosis
Osteogenesis
/ genetics
Pedigree
Primary Cell Culture
Profilins
/ genetics
Radiography
Severity of Illness Index
Exome Sequencing
Young Adult
PFN1 gene
Paget disease of bone
bisphosphonates
osteoclast
whole exome sequencing
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 08 2020
01 08 2020
Historique:
received:
24
03
2020
accepted:
05
05
2020
pubmed:
12
5
2020
medline:
9
2
2021
entrez:
12
5
2020
Statut:
ppublish
Résumé
Paget disease of bone (PDB) is a metabolic bone disease whose genetic cause remains unknown in up to 50% of familial patients. Our aim was to investigate the underlying genetic defect in a large pedigree with a severe, early onset, autosomal dominant form of PDB across 3 generations. Whole exome sequencing was performed in affected and unaffected family members, and then mutation screening was replicated in a sample of PDB patients with early-onset, polyostotic PDB. We identified a frameshift D107Rfs*3 mutation in PFN1 (encoding for profilin 1, a highly conserved regulator of actin-polymerization and cell motility) causing the truncation of the C-terminal part of the protein. The mutation was also detected in a 17-year-old asymptomatic family member who upon biochemical and radiological analyses was indeed found to be affected. Sequencing of the entire PFN1 coding region in unrelated PDB patients identified the same mutation in 1 patient. All mutation carriers had a reduced response to bisphosphonates, requiring multiple zoledronate infusions to control bone pain and achieve biochemical remission over a long term. In vitro osteoclastogenesis in peripheral blood mononuclear cells (PBMCs) from mutation carriers showed a higher number of osteoclasts with PDB-like features. A similar phenotype was observed upon PFN1 silencing in murine bone marrow-derived monocytes, suggesting that the frameshift PFN1 mutation confers a loss of function in profilin 1 activity that induces PDB-like features in the osteoclasts, likely due to enhanced cell motility and actin ring formation. Our findings indicate that PFN1 mutation causes an early onset, polyostotic PDB-like disorder.
Identifiants
pubmed: 32392277
pii: 5835857
doi: 10.1210/clinem/dgaa252
pii:
doi:
Substances chimiques
PFN1 protein, human
0
Pfn1 protein, mouse
0
Profilins
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.